Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04748848
Title A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celgene
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL

No variant requirements are available.